BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26985832)

  • 1. High Mortality of Disseminated Non-Tuberculous Mycobacterial Infection in HIV-Infected Patients in the Antiretroviral Therapy Era.
    Kobayashi T; Nishijima T; Teruya K; Aoki T; Kikuchi Y; Oka S; Gatanaga H
    PLoS One; 2016; 11(3):e0151682. PubMed ID: 26985832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection.
    Liao CH; Chen MY; Hsieh SM; Sheng WH; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2004 Feb; 37(1):50-6. PubMed ID: 15060688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
    Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
    Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, spectrum and outcome of immune reconstitution syndrome in HIV-infected children after initiation of antiretroviral therapy.
    Gkentzi D; Tebruegge M; Tudor-Williams G; Walters S; Lyall H; Sharland M; Doerholt K
    Pediatr Infect Dis J; 2014 Sep; 33(9):953-8. PubMed ID: 24618936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in mycobacterial disease among HIV-infected children in the highly active antiretroviral therapy era (1997-2008).
    Jensen J; Álvaro-Meca A; Micheloud D; Díaz A; Resino S
    Pediatr Infect Dis J; 2012 Mar; 31(3):278-83. PubMed ID: 22016082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and clinical characteristic of mycobacterial infections in human immunodeficiency virus-infected patients in Siriraj Hospital.
    Chayakulkeeree M; Naksanguan T
    J Med Assoc Thai; 2015 Mar; 98(3):238-44. PubMed ID: 25920293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routinely detected indicators in plasma have a predictive effect on the identification of HIV-infected patients with non-tuberculous mycobacterial and tuberculous infections.
    Cai RT; Yu FX; Tao Z; Qian XQ; Chen J; Lu HZ
    Infect Dis Poverty; 2017 Nov; 6(1):132. PubMed ID: 29092717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in nontuberculous mycobacterial disease in hospitalized subjects in Spain (1997-2010) according to HIV infection.
    Álvaro-Meca A; Rodríguez-Gijón L; Díaz A; Gil Á; Resino S
    HIV Med; 2015 Sep; 16(8):485-93. PubMed ID: 25854195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcomes of disseminated infections caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 2004-2008.
    Chou CH; Chen HY; Chen CY; Huang CT; Lai CC; Hsueh PR
    Scand J Infect Dis; 2011 Jan; 43(1):8-14. PubMed ID: 20849364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
    Knoll BM; Kappagoda S; Gill RR; Goldberg HJ; Boyle K; Baden LR; Fuhlbrigge AL; Marty FM
    Transpl Infect Dis; 2012 Oct; 14(5):452-60. PubMed ID: 22676720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy.
    Kohli R; Lo Y; Howard AA; Buono D; Floris-Moore M; Klein RS; Schoenbaum EE
    Clin Infect Dis; 2005 Sep; 41(6):864-72. PubMed ID: 16107987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
    Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
    CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia.
    McCarthy KD; Cain KP; Winthrop KL; Udomsantisuk N; Lan NT; Sar B; Kimerling ME; Kanara N; Lynen L; Monkongdee P; Tasaneeyapan T; Varma JK
    Am J Respir Crit Care Med; 2012 May; 185(9):981-8. PubMed ID: 22345581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
    Marras TK; Morris A; Gonzalez LC; Daley CL
    Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
    Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of bloodstream infections and predictive factors of mortality among HIV-infected adult patients in Thailand in the era of highly active antiretroviral therapy.
    Kiertiburanakul S; Watcharatipagorn S; Chongtrakool P; Santanirand P
    Jpn J Infect Dis; 2012; 65(1):28-32. PubMed ID: 22274154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.